EUVIMEDEUVIMED entdecken
Crossref

Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper

Daniel Hughes, Kwee Yong iD, Karthik Ramasamy iD, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin iD, Guy Pratt iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Daniel Hughes und 8 weiteren Autor:innen. Beteiligte Einrichtung: UCL Cancer Institute, University College London, London, UK. Hauptthemen laut MEDLINE: Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, Hematology. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 137 Literaturangaben. Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma is a bone marrow-based plasma cell tumour that develops from asymptomatic pre-cursor conditions smouldering myeloma and monoclonal gammopathy of uncertain significance and all are characterised by the presence of a monoclonal protein in the blood. Diagnosis and distinction between these conditions is based on blood tests, the bone marrow biopsy and cross sectional imaging. There are various risk stratification models that group patients with smouldering myeloma into risk groups based on risk of progression to symptomatic disease. Management is mainly observational for patients with smouldering myeloma although clinical trials for high-risk disease may be available. Restaging is required if evidence for progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaHematologyHumansPlasma CellsDisease Progression

Stichwörter der Autor:innen

MGUSmultiple myelomamyeloma therapymyeloma

Autor:innen und Institutionen

  • UCL Cancer Institute, University College London, London, UK.
  • Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Oxford Translational Myeloma Centre, NDORMS, University of Oxford, Oxford, UK.
  • Epsom and St Helier University Hospitals NHS Trust, Sutton, UK.
  • The Mid Yorkshire Teaching Hospitals NHS Trust, Wakefield, UK.
  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

ORCID-Profile: Kwee Yong, Karthik Ramasamy, Neil Rabin, Guy Pratt

Förderung

  • Medical Research Council

Zitieren

APA

Hughes, D., Yong, K., Ramasamy, K., Stern, S., Boyle, E., Ashcroft, J., Basheer, F., Rabin, N., & Pratt, G. (2024). Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British Journal of Haematology. https://doi.org/10.1111/bjh.19333

Vancouver

Hughes D, Yong K, Ramasamy K, Stern S, Boyle E, Ashcroft J, et al. Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British Journal of Haematology. 2024. doi:10.1111/bjh.19333

BibTeX
@article{Hughes2024,
  author = {Hughes, Daniel and Yong, Kwee and Ramasamy, Karthik and Stern, Simon and Boyle, Eileen and Ashcroft, John and Basheer, Faisal and Rabin, Neil and Pratt, Guy},
  title = {Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19333}
}
Kostenlos starten →